Posts by Sandra Ansanay-Alex
Stalicla Secures CHF 2 Million Financing Led by Addex Therapeutics
STALICLA SA, a Geneva-based clinical-stage biotech company pioneering precision medicine for neurodevelopmental and neuropsychiatric disorders, announced the successful closing of a CHF 2 million financing led by Addex Therapeutics. This financing will sustain operations and program development in neurodevelopmental disorders as Stalicla prepares for its upcoming Series C and the partnering of key programs.…
Read MoreTimeline® and Cellcosmet Get a Science of Skin Award
The Science of Skin Awards, hosted by Skincare Anarchy LLC, stand as a global benchmark for scientific integrity and innovation in skincare. Each year, only ten brands are selected for this prestigious honor, and two Swiss brands, Timeline® and Cellcosmet are among the winners. The Science of Skin Awards recognize skincare companies that leverage…
Read MoreTwo UNIGE Life Sciences Projects Get a CHF 100’000 innoLIFE Grant
Two UNIGE scientists, Sanae El Harane from the Department of Medicine, and Maude Rolland, from the Department of Surgery received a CHF 100’000 innoLIFE grant to pursue their research. Turning academic breakthroughs into real-world healthcare solutions is no small feat. In fields like pharma, biotech, and medtech—where regulation is stringent and the path to…
Read MoreAdiposs Raises CHF 4 million in Series A
Adiposs SA, a Geneva-based clinical-stage Swiss life sciences company announced the successful closing of a CHF 4 million Series A financing round. The round was syndicated by Swiss and Taiwanese VC firms, European family offices and high-net-worth individual investors. Adiposs is pioneering the development of the first imaging product for brown fat designed to…
Read MoreInTeeth Receives a CHF 100,000 FIF Seed Loan
InTeeth, a University of Geneva spinoff has developed a patented InLiner, the first-ever lingual aligner that is fixed behind the teeth. Three high-potential projects from Geneva have been awarded funding through the FONGIT Innovation Fund (FIF), reinforcing the canton’s support for breakthrough technologies in life sciences and precision engineering. InTeeth received a CHF 100,000…
Read MoreBeech Biotech Awarded $1.9 million by the Gates Foundation
Beech Biotech, a Lausanne-based biopharmaceutical company creating “Mother only” monoclonals to treat complications of pregnancy, has been awarded a $1.9 million grant by the Gates Foundation for the development of its breakthrough therapeutic approach in preeclampsia. Preeclampsia is a leading cause worldwide of maternal morbidity and mortality, premature birth, stillbirth, and neonatal death. Each…
Read MoreHAYA Therapeutics Named a 2025 Technology Pioneer by the World Economic Forum
HAYA Therapeutics, a Biopôle Lausanne based startup has been selected as one of the 100 early-stage companies in the World Economic Forum’s 2025 Technology Pioneers cohort! This prestigious recognition highlights the company’s pioneering work in developing next-generation, disease-modifying precision medicines. HAYA is harnessing the power of the human genome’s dark matter to create precise RNA-based…
Read MoreAtinary and Chemspeed Partner to Launch Self-Driving Labs Powered by AI and Robotics
Atinary Technologies and Chemspeed Technologies AG have joined forces in a strategic collaboration to accelerate R&D innovation by combining artificial intelligence, robotics, and automation into fully integrated Self-Driving Labs. As a first milestone, the Atinary SDLabs no-code AI platform is now fully integrated with Chemspeed’s advanced automation systems, allowing real-time, closed-loop optimization and control.…
Read Moreten23 health Joins the “Alliance for RTU”
ten23 health joins the “Alliance for RTU” – an association to advance technical exchange for ready-to-use (RTU) containers in sterile manufacturing ten23 health, a CDTMO based in Basel and Visp,has joined the „Alliance for RTU“, an association to advance technical exchange for ready-to-use (RTU) containers in sterile manufacturing. The Alliance for RTU was formed…
Read MoreSuperlab Suisse to Open at Campus Biotech in 2026
Superlab Suisse, a leading provider of next-generation lab infrastructure, has announced the opening of a fully serviced lab facility at Campus Biotech in Geneva, scheduled for January 2026. This milestone marks a significant step in the evolution of Geneva as one of the most dynamic and fast-growing life science clusters in the world. Located…
Read More